Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in ...

Background: Integrin subunit alpha L (ITGAL) is crucial for activating CD8 + T cells through magnesium-mediated immune synapse formation and specific cytotoxicity. ITGAL might exert an important ...

Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Study Links Methylmalonic Acid to Weakening of Immune Cells in Lung Cancer Oct. 31 ... of methylmalonic acid and the weakening of CD8+ T cells, shedding light on potential pathways through ...

Professor Heung Kyu Lee, KAIST Department of Biological Sciences, and Dr. Keun Bon Ku >Immunotherapy, which enhances the ...

Scientists push CAR T cell therapy beyond blood cancers, unlocking potential for targeting solid tumors with enhanced delivery, resilience, and precision in the face of tough obstacles.

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...

11月7日，Cancer Cell期刊在线发表了题为“Targeting the immune privilege of tumor-initiating cells to enhance cancer ...

In the oral presentation, the investigators reported ongoing improved survival compared to historical controls, with 3 out of ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

An immune-cell therapy shrank children’s brain tumors, restored neurologic function and — for one participant in a Stanford Medicine clinical trial — erased all detectable traces of a brain cancer ...

For some years now, CAR T-cells have been bringing new momentum to immunotherapies against cancer. How it works: experts take the patient's T-cells and reprogram them in the lab so that they can ...